G
GMAB
Genmab
25.10
+0.30+1.21%After Hours: 25.10 0.00 0.00%17:40 06/09 EDT
OPEN/PREV CLOSE24.87/24.80
TODAY RANGE24.71-25.17
VOL1.33M
MARKET CAP16.13B
52 WEEK RANGE20.23-35.43
AVG VOL (3M)1.82M
% TURNOVER0.21%
TURNOVER--
P/E (TTM)19.01
% RANGE1.85%
EPS(TTM)1.320
P/E(FORWARD)24.85
P/B2.712
BVPS9.26
DIVIDEND--
P/S4.158
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP16.13B
SHARES OUTSTANDING642.51M
NEXT EARNINGS02/10-02/16
FREE FLOAT642.49M
LOT SIZE1
EX-DATE05/01/2018
News
Press Releases
Financial Reports
Profile
Seeking Alpha·18h ago
Pfizer, Zai Lab win China nod for cervical cancer therapy Tivdak
Benzinga·4d ago
Why Is ADC Therapeutics Stock Falling On Friday?
Benzinga·5d ago
Why Is ADC Therapeutics Stock Falling Thursday?
TipRanks·06/02 09:56
Wells Fargo Gives a Buy Rating to Genmab (GMAB)
TipRanks·05/29 21:19
Genmab Reports Board Member Share Sale Under EU Market Abuse Rules
TipRanks·05/27 15:30
Genmab assumed with a Buy at Truist
Seeking Alpha·05/27 15:25
Corbus Pharmaceuticals: I'd Preach Caution After Selloff On Latest Data Drop
TipRanks·05/27 12:32
Genmab (GMAB) Has a New Rating from Truist Financial
TipRanks·05/26 10:58
Wells Fargo Keeps Their Buy Rating on Genmab (GMAB)
PUBT·05/21 21:04
Genmab to present epcoritamab data at ASCO, EHA meetings
Same Industry
Name/Symbol
Change%
Price